For decades, the Food and Drug Administration was the undisputed global gold standard for regulation. While other nations might approve drugs faster or cheaper, an FDA approval was special. It was a guarantee that a product had survived a meticulous review by career scientists who were cautious to a fault and insulated from undue political influence.
During my 15 years at the agency — serving as a reviewer, special assistant to the commissioner, and founding director of the Office of Biotechnology — we understood that the agency’s legitimacy depended on a firewall between scientific evidence and political ideology.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.